ADCT logo

ADC Therapeutics SA (ADCT) Company Overview

Profile

Full Name:

ADC Therapeutics SA

Sector:

Healthcare

Industry:

Biotechnology

Country:

Switzerland

IPO:

May 18, 2020

Indexes:

Not included

Website:

http://www.adctherapeutics.com

Description:

ADC Therapeutics SA is a biotechnology company focused on developing targeted therapies for cancer. They specialize in antibody-drug conjugates (ADCs), which combine antibodies with potent drugs to selectively kill cancer cells while minimizing damage to healthy tissue. Their innovative treatments aim to improve patient outcomes in oncology.

Key Details

Price

$1.58

Market Cap

$152.77 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$69.56 M(-66.86% YoY)

Annual EPS

-$2.94(-46.27% YoY)

PE Ratio

-

Annual ROE

161.93%

Annual Debt To Equity

-0.76

Beta

1.47

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 24, 25 Stephens & Co.
Overweight
Jan 6, 25 HC Wainwright & Co.
Buy
Dec 12, 24 Guggenheim
Buy
Dec 11, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Stephens & Co.
Overweight
Aug 8, 24 HC Wainwright & Co.
Buy
Aug 7, 24 RBC Capital
Outperform
May 30, 24 Cantor Fitzgerald
Overweight
May 7, 24 HC Wainwright & Co.
Buy
Apr 15, 24 HC Wainwright & Co.
Buy

Screeners with ADCT included

Growing Shares Outstanding
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.58
ADCT price is $1.58

Price All-time High

$51.05
ADCT price is currently -96.90% below its historical high of $51.05

Price Analysts Target

$8.00
ADCT price is currently -80.25% lower than the consensus analysts' forecast

Price Most Recent Change

-3.66%
ADCT price was down -3.66% on Feb 27, 2025

Price YTD Change

-24.04%
ADCT price is down -24.04% since January 1st

Price 3-Year Change

-90.67%
ADCT price is down -90.67% over the past 3 years

Market cap

Market Cap

$152.77 M
ADCT market capitalization is $152.77 million

Market Cap 3-Year Change

-88.25%
ADCT market capitalization is down -88.25% over the past 3 years

Market Cap All-time High

$3.61 B
ADCT market capitalization is currently -95.77% below its historical high of $3.61 billion

Market Cap Sector Rank

51.19%
ADCT market capitalization is higher than 51.19% of companies in Healthcare sector

Technical

Beta

1.47
ADCT beta is 1.47

200-day SMA

$2.75
ADCT price is currently -42.53% below its 200-day simple moving average

14-day RSI

44.67
ADCT 14-day relative strength index is 44.67

30-day Relative Volume

0.50
ADCT 30-day relative volume is 0.50

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$69.56 M
ADCT annual revenue is $69.56 million

Annual Revenue Analysts Estimate

$72.88 M
ADCT annual revenue is currently -4.56% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-66.86%
ADCT annual revenue is down -66.86% year-on-year

Annual Revenue Sector Rank

51.81%
ADCT annual revenue is higher than 51.81% of companies in Healthcare sector

Profit

Annual Gross Profit

$67.03 M
ADCT annual gross profit is $67.03 million

Annual Gross Margin

96.36%
ADCT annual gross profit margin is 96.36%

Annual Operating Profit

-$165.05 M
ADCT annual operating income is -$165.05 million

Annual Operating Margin

-237.29%
ADCT annual operating profit margin is -237.29%

Annual Net Income

-$240.05 M
ADCT annual net profit is -$240.05 million

Annual Net Margin

-345.11%
ADCT annual net profit margin is -345.11%

EPS

Annual EPS

-$2.94
ADCT annual earnings per share is -$2.94

Annual EPS Analysts Estimate

-
ADCT annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-46.27%
ADCT annual earnings per share is down -46.27% year-on-year

Annual EPS Sector Rank

33%
ADCT annual earnings per share is higher than 33% of companies in Healthcare sector

ROA & ROE

Annual ROA

-56.77%
ADCT annual return on assets is -56.77%

Annual ROE

161.93%
ADCT annual return on equity is 161.93%

EBIT & EBITDA

Annual EBIT

-$149.09 M
ADCT annual earnings before interest & taxes is -$149.09 million

Annual EBITDA

-$145.83 M
ADCT annual EBITDA is -$145.83 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ADCT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ADCT price to earnings ratio is unknown

PB Ratio

PB Ratio

-0.89
ADCT price to book ratio is -0.89

PB Ratio Sector Rank

9.92%
ADCT price to book ratio is higher than 9.92% of companies in Healthcare sector

PS Ratio

PS Ratio

2.16
ADCT price to sales ratio is 2.16

PS Ratio Sector Rank

41.48%
ADCT price to sales ratio is higher than 41.48% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.05 M
ADCT enterprise value is $3.05 million

Enterprise Value Sector Rank

15.83%
ADCT enterprise value is higher than 15.83% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.03
ADCT EV/EBITDA is -0.03

EV/EBITDA Sector Rank

65.61%
ADCT EV/EBITDA is higher than 65.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.97
ADCT annual current ratio is 4.97

Annual Quick Ratio

4.73
ADCT annual quick ratio is 4.73

Leverage

Annual Debt To Equity

-0.76
ADCT annual debt to equity ratio is -0.76

Annual Interest Coverage Ratio

-3.22
ADCT annual interest coverage ratio is -3.22

Risk & Stability

Piotroski F-Score

2
ADCT piotroski f-score is 2

Altman Z-Score

-5.37
ADCT altman z-score is -5.37

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$354.78 M
ADCT annual total assets is $354.78 million

Annual Non Current Assets

$18.49 M
ADCT annual long term assets is $18.49 million

Annual Current Assets

$336.29 M
ADCT annual total current assets is $336.29 million

Annual Cash & Cash Equivalents

$278.60 M
ADCT annual cash & cash equivalents is $278.60 million

Equity

Annual Book Value

-$148.25 M
ADCT annual book value is -$148.25 million

Annual Working Capital

$268.62 M
ADCT annual working capital is $268.62 million

Liabilities

Annual Total Liabilities

$503.03 M
ADCT annual total liabilities is $503.03 million

Annual Total Long Term Liabilities

$435.36 M
ADCT annual total long term liabilities is $435.36 million

Annual Current Liabilities

$67.67 M
ADCT annual total current liabilities is $67.67 million

Annual Accounts Payable

$15.57 M
ADCT annual accounts payable is $15.57 million

Debt

Annual Total Debt

$124.38 M
ADCT annual total debt is $124.38 million

Annual Total Debt 1-Year Change

+5.97%
ADCT annual total debt is up +5.97% year-on-year

Annual Long Term Debt

$122.91 M
ADCT annual long term debt is $122.91 million

Annual Short Term Debt

$1.47 M
ADCT annual short term debt is $1.47 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$234.61 M
ADCT annual total expenses is $234.61 million

Annual Operating Expenses

$232.08 M
ADCT annual total operating expenses is $232.08 million

Annual Cost Of Goods Sold

$2.53 M
ADCT annual cost of goods sold is $2.53 million

Annual SGA

$105.89 M
ADCT annual SGA is $105.89 million

Annual D&A

$3.27 M
ADCT annual depreciation & amortization is $3.27 million

Annual Interest Expense

$46.33 M
ADCT annual interest expense is $46.33 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$118.69 M
ADCT annual cash flow from operations is -$118.69 million

Annual CFO 1-Year Change

+14.19%
ADCT annual cash flow from operations is up +14.19% year-on-year

Annual CFI

-$3.22 M
ADCT annual cash flow from investing activities is -$3.22 million

Annual CFI 1-Year Change

-368.12%
ADCT annual cash flow from investing activities is down -368.12% year-on-year

Annual CFF

$73.88 M
ADCT annual cash flow from financing activities is $73.88 million

Annual CFF 1-Year Change

+8335.79%
ADCT annual cash flow from financing activities is up +8335.79% year-on-year

Free CashFlow

Annual FCF

-$121.90 M
ADCT annual free cash flow is -$121.90 million

Annual FCF 1-Year Change

+12.3%
ADCT annual free cash flow is up +12.3% year-on-year

CAPEX

Annual CAPEX

$3.22 M
ADCT annual capital expenditures is $3.22 million

Annual CAPEX 1-Year Change

+368.12%
ADCT annual capital expenditures is up +368.12% year-on-year

Institutional Ownership

Similar stocks

Renovaro Biosciences (RENB)
NKTR logo
Nektar Therapeutics (NKTR)
American Oncology Network (AONC)
GLSI logo
Greenwich LifeSciences (GLSI)
THRD logo
Third Harmonic Bio (THRD)
PBYI logo
Puma Biotechnology (PBYI)
MNPR logo
Monopar Therapeutics (MNPR)
MGNX logo
MacroGenics (MGNX)
EDIT logo
Editas Medicine (EDIT)

FAQ

  • What is the ticker symbol for ADC Therapeutics SA?
  • Does ADC Therapeutics SA pay dividends?
  • What sector is ADC Therapeutics SA in?
  • What industry is ADC Therapeutics SA in?
  • What country is ADC Therapeutics SA based in?
  • When did ADC Therapeutics SA go public?
  • Is ADC Therapeutics SA in the S&P 500?
  • Is ADC Therapeutics SA in the NASDAQ 100?
  • Is ADC Therapeutics SA in the Dow Jones?
  • When was ADC Therapeutics SA's last earnings report?
  • When does ADC Therapeutics SA report earnings?
  • Should I buy ADC Therapeutics SA stock now?

What is the ticker symbol for ADC Therapeutics SA?

The ticker symbol for ADC Therapeutics SA is NYSE:ADCT

Does ADC Therapeutics SA pay dividends?

No, ADC Therapeutics SA does not pay dividends

What sector is ADC Therapeutics SA in?

ADC Therapeutics SA is in the Healthcare sector

What industry is ADC Therapeutics SA in?

ADC Therapeutics SA is in the Biotechnology industry

What country is ADC Therapeutics SA based in?

ADC Therapeutics SA is headquartered in Switzerland

When did ADC Therapeutics SA go public?

ADC Therapeutics SA's initial public offering (IPO) was on May 18, 2020

Is ADC Therapeutics SA in the S&P 500?

No, ADC Therapeutics SA is not included in the S&P 500 index

Is ADC Therapeutics SA in the NASDAQ 100?

No, ADC Therapeutics SA is not included in the NASDAQ 100 index

Is ADC Therapeutics SA in the Dow Jones?

No, ADC Therapeutics SA is not included in the Dow Jones index

When was ADC Therapeutics SA's last earnings report?

ADC Therapeutics SA's most recent earnings report was on Nov 7, 2024

When does ADC Therapeutics SA report earnings?

The next expected earnings date for ADC Therapeutics SA is Mar 13, 2025

Should I buy ADC Therapeutics SA stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions